Commit To Purchase Xeris Pharmaceuticals At $7.50, Earn 21.2% Annualized Using Options
December 02, 2019 at 12:04 PM EST
Investors considering a purchase of Xeris Pharmaceuticals Inc (XERS) shares, but tentative about paying the going market price of $8.66/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the January 2020 put at the $7.50 strike, which has a bid at the time of this writing of 20 cents..